These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 39370272)

  • 1. The utility of MRI for the preoperative differential diagnosis of uterine sarcoma and leiomyoma: a single-center study.
    Yazawa H; Yazawa R; Anjo K; Inazuki A; Kikuta M
    Fukushima J Med Sci; 2024 Oct; 70(4):211-218. PubMed ID: 39370272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of Clinical Parameters and Multiparametric MRI as Predictive Factors for Differentiating Uterine Sarcoma From Atypical Leiomyoma.
    Bi Q; Xiao Z; Lv F; Liu Y; Zou C; Shen Y
    Acad Radiol; 2018 Aug; 25(8):993-1002. PubMed ID: 29422425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating Uterine Sarcoma From Atypical Leiomyoma on Preoperative Magnetic Resonance Imaging Using Logistic Regression Classifier: Added Value of Diffusion-Weighted Imaging-Based Quantitative Parameters.
    Kim H; Rha SE; Shin YR; Kim EH; Park SY; Lee SL; Lee A; Kim MR
    Korean J Radiol; 2024 Jan; 25(1):43-54. PubMed ID: 38184768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma / smooth muscle tumor with uncertain malignant potential and benign leiomyoma.
    Lin G; Yang LY; Huang YT; Ng KK; Ng SH; Ueng SH; Chao A; Yen TC; Chang TC; Lai CH
    J Magn Reson Imaging; 2016 Feb; 43(2):333-42. PubMed ID: 26383110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI.
    Malek M; Rahmani M; Seyyed Ebrahimi SM; Tabibian E; Alidoosti A; Rahimifar P; Akhavan S; Gandomkar Z
    Cancer Imaging; 2019 Apr; 19(1):20. PubMed ID: 30935419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Algorithm to Differentiate Benign Atypical Leiomyomas from Malignant Uterine Sarcomas with Diffusion-weighted MRI.
    Abdel Wahab C; Jannot AS; Bonaffini PA; Bourillon C; Cornou C; Lefrère-Belda MA; Bats AS; Thomassin-Naggara I; Bellucci A; Reinhold C; Fournier LS
    Radiology; 2020 Nov; 297(2):361-371. PubMed ID: 32930650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leiomyoma or sarcoma? MRI performance in the differential diagnosis of sonographically suspicious uterine masses.
    Valletta R; Corato V; Lombardo F; Avesani G; Negri G; Steinkasserer M; Tagliaferri T; Bonatti M
    Eur J Radiol; 2024 Jan; 170():111217. PubMed ID: 38042020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis of uterine smooth muscle tumors using diffusion-weighted imaging: correlations with the apparent diffusion coefficient and cell density.
    Tasaki A; Asatani MO; Umezu H; Kashima K; Enomoto T; Yoshimura N; Aoyama H
    Abdom Imaging; 2015 Aug; 40(6):1742-52. PubMed ID: 25526683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of PET/CT to exclude leiomyoma in patients with lesions suspicious for uterine sarcoma on MRI.
    Kusunoki S; Terao Y; Ujihira T; Fujino K; Kaneda H; Kimura M; Ota T; Takeda S
    Taiwan J Obstet Gynecol; 2017 Aug; 56(4):508-513. PubMed ID: 28805609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of ultrasonography and magnetic resonance imaging for the characterization of uterine mesenchymal tumors.
    Bonneau C; Thomassin-Naggara I; Dechoux S; Cortez A; Darai E; Rouzier R
    Acta Obstet Gynecol Scand; 2014 Mar; 93(3):261-8. PubMed ID: 24372487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative diagnosis of atypical pelvic leiomyoma and sarcoma: the potential role of diffusion-weighted imaging.
    Valdes-Devesa V; Jimenez MDM; Sanz-Rosa D; Espada Vaquero M; Alvarez Moreno E; Sainz de la Cuesta Abbad R
    J Obstet Gynaecol; 2019 Jan; 39(1):98-104. PubMed ID: 30207503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multiparametric MRI-based machine learning to distinguish between uterine sarcoma and benign leiomyoma: comparison with
    Nakagawa M; Nakaura T; Namimoto T; Iyama Y; Kidoh M; Hirata K; Nagayama Y; Oda S; Sakamoto F; Shiraishi S; Yamashita Y
    Clin Radiol; 2019 Feb; 74(2):167.e1-167.e7. PubMed ID: 30471748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine Learning to Differentiate T2-Weighted Hyperintense Uterine Leiomyomas from Uterine Sarcomas by Utilizing Multiparametric Magnetic Resonance Quantitative Imaging Features.
    Nakagawa M; Nakaura T; Namimoto T; Iyama Y; Kidoh M; Hirata K; Nagayama Y; Yuki H; Oda S; Utsunomiya D; Yamashita Y
    Acad Radiol; 2019 Oct; 26(10):1390-1399. PubMed ID: 30661978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiating cellular leiomyoma from uterine sarcoma and atypical leiomyoma using multi-parametric MRI.
    Wang C; Zheng X; Zhou Z; Shi Y; Wu Q; Lin K
    Front Oncol; 2022; 12():1005191. PubMed ID: 36276145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative ultrasound-guided needle biopsy of 63 uterine tumors having high signal intensity upon T2-weighted magnetic resonance imaging.
    Tamura R; Kashima K; Asatani M; Nishino K; Nishikawa N; Sekine M; Serikawa T; Enomoto T
    Int J Gynecol Cancer; 2014 Jul; 24(6):1042-7. PubMed ID: 24927248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of 3 T MR spectroscopy, diffusion-weighted MRI, and apparent diffusion coefficient value for distinguishing benign from malignant myometrial tumours.
    Rahimifar P; Hashemi H; Malek M; Ebrahimi S; Tabibian E; Alidoosti A; Mousavi A; Yarandi F
    Clin Radiol; 2019 Jul; 74(7):571.e9-571.e18. PubMed ID: 31010584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validating the diagnostic accuracy of an MRI-based scoring system for differentiating benign uterine leiomyomas from leiomyosarcomas.
    Al Khuri M; Al Salmi I; Al Ajmi H; Al Hadidi A; Alabousi A; Haider E; Vasudev P; Al Salmi A; Jose S; Alrahbi N
    Int J Gynecol Cancer; 2024 Jul; 34(7):1027-1033. PubMed ID: 38658016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of magnetic resonance imaging for differentiating malignant mesenchymal tumors of the uterus from T2-weighted hyperintense leiomyomas.
    Matsuura K; Inoue K; Hoshino E; Yasuda M; Hasegawa K; Okada Y; Baba Y; Kozawa E
    Jpn J Radiol; 2022 Apr; 40(4):385-395. PubMed ID: 34750737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas.
    Tamai K; Koyama T; Saga T; Morisawa N; Fujimoto K; Mikami Y; Togashi K
    Eur Radiol; 2008 Apr; 18(4):723-30. PubMed ID: 17929022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperintense uterine myometrial masses on T2-weighted magnetic resonance imaging: differentiation with diffusion-weighted magnetic resonance imaging.
    Takeuchi M; Matsuzaki K; Nishitani H
    J Comput Assist Tomogr; 2009; 33(6):834-7. PubMed ID: 19940646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.